Surveillance

This slide set provides an overview of the epidemiology of pediatric TB in the United States from 1993-2015.

This instructional packet includes a series of four print-based modules addressing TB contact investigation, case management, and confidentiality. It also provides information on managing multidrug-resistant TB and on DOT.

This fact sheet presents data on the distribution of TB cases among the Asian/Pacific Islander populations of Los Angeles County in 2003.

The main purpose of this guide is to describe and explain how to design, implement and analyse an inventory study to measure TB under-reporting. The guide also explains how to apply capture-recapture methods to estimate TB incidence, emphasizing the conditions that must be fulfilled for these methods to be used. This guide is intended for use by NTP managers, researchers including epidemiologists and statisticians, and agencies that provide financial and technical support for inventory studies.

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.

This report, updated annually, details the global epidemiology of TB based on the data supplied by the national TB programs from WHO member states.

This book describes the technical framework and principles used to implement DOTS-Plus in resource poor settings. It also provides a number of case histories that illustrate common challenges in the treatment of MDR TB patients. The book includes protocols that can be used under DOTS-Plus program conditions to manage common complication of this therapy.

This document revises previous WHO standard case definitions for TB and drug-resistant TB, the categories used to assign outcomes, and the standard reporting framework for TB.

A fact sheet for individuals experiencing a TB contact investigation. This material includes information on what happens in a TB contact investigation and how to protect others from active TB disease.

These guidelines have been developed to assist national TB control programs (NTPs) in adopting specific anti-TB drug resistance surveillance systems to measure susceptibility to first-line TB drugs.